Illinois Health and Hospital Association

11/20/2026 | Press release | Distributed by Public on 11/20/2026 16:07

IHA Daily Briefing: November 20

HHS Awards $47 Million Awards to Test Chronic Disease Prevention Approaches in Medicare
The U.S. Dept. of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), today announced $47 million in awards to 15 organizations, including Northwestern University and the University of Illinois Board of Trustees to test new approaches to chronic disease prevention and management for people with Medicare. Through the Make America Healthy Again: Enhancing Lifestyle and Evaluating Value-based Approaches Through Evidence (MAHA ELEVATE) Model recipients will test functional or lifestyle medical interventions that complement conventional medical care. The model will evaluate whether these approaches improve quality of care and reduce costs.


The CMS Innovation Center received nearly 450 applications for the MAHA ELEVATE Model from academic institutions, nonprofits, community-based organizations, health providers, local governments, technology companies, and others across the country. The 15 awardees were selected through a competitive merit review process that considered each proposal's evaluability, policy compliance, clinical soundness and cost-savings potential.


The 15 award recipients have been selected to receive funding to test interventions focused on chronic conditions including heart failure, dementia, diabetes, obesity and hypertension. To view the full list of awardees, click here. Read the fact sheet here.


FDA Approves Drug to Treat Neurological Symptoms of Type 3 Gaucher Disease
The Food and Drug Administration (FDA) this week approved Infilbray (venglustat) tablets, the first treatment for the neurological symptoms of Type 3 Gaucher disease (GD3) in adults and pediatric patients weighing at least 15 kg (approximately 33 pounds). According to a news release, Infilbray crosses the blood-brain barrier to reduce the accumulation of harmful substances in the body and brain.

"For patients with Type 3 Gaucher disease, harmful substances build up in the brain without a way to stop them, but this drug's ability to cross the blood-brain barrier means it can get to the source of the buildup driving the neurological symptoms," said Acting FDA Commissioner Kyle Diamantas, JD. "This approval reflects the FDA's commitment to advancing therapeutic options for patients with rare diseases and brings an important new treatment to patients and the healthcare providers who care for them."

GD3 is a rare, inherited condition in which the body cannot properly break down fatty substances, called glucosphingolipids, due to a deficient or malfunctioning enzyme. As these substances accumulate in organs, tissues and the brain, patients experience a wide range of serious health problems over time. Unlike type 1 Gaucher disease, GD3 also affects the brain and nervous system, causing difficulties with balance, coordination, speech, memory, and thinking-symptoms that can worsen progressively and significantly impact quality of life. Infilbray works as a glucosylceramide synthase inhibitor, reducing the buildup of harmful substances throughout the body and, critically, within the brain.

The FDA's approval of Infilbray is supported by data from a randomized, double-blind, multicenter clinical study enrolling 43 patients aged 12 years and older with GD3 who had previously been treated with enzyme replacement therapy and had achieved systemic disease stabilization.

Infilbray was granted Orphan Drug designation as well as Priority Review. The approval of Infilbray was granted to Genzyme Corporation, a Sanofi company.

Registration Open for Winter/Spring ECHO-Chicago Series
ECHO-Chicago (Extension for Community Health Outcomes) is a statewide live virtual online workforce training and capacity building program housed at the University of Chicago that focuses on promoting the use of evidence-based best practices in clinical and nonclinical settings. Participating providers gain knowledge and skills for managing common, chronic physical and mental health conditions that they translate into practice with the support of their peers.

ECHO-Chicago's complimentary telementoring sessions are held weekly for one hour. CME credit is offered for each session attended, with nursing credit also available. Click here for more information about the ECHO-Chicago upcoming series, including registration information and session topics and dates.

ECHO-Chicago has trained more than 8,000 providers and healthcare professionals from more than 2,100 organizations since 2010. Across series, 88% of participants report increasing confidence in their skills, and 75% report making at least one change to their practice by the end of training. Participants have also reported a 20-30% reduction in referrals to specialty care.

Funding Opportunity: Launch or Expand DSMES Services
The CARES: Cook County Diabetes Management & Prevention team has announced a new Request for Application (RFA) funding opportunity to support type 2 diabetes management service providers with funding to launch and/or expand Diabetes Self-Management Education and Support (DSMES) services for people with diabetes at highest risk of type 2 unmanaged diabetes in Cook County.

Selected applicants will receive the below-described support:

  • $10,000 for an organization working towards establishing new DSMES services in Cook County; or
  • $35,000 for an organization scaling existing DSMES services to two or more new locations within Cook County

More information about the funding opportunity, including program background, eligibility requirements and application information can be found here. RFA information written Spanish can be found here. The application must be submitted by Dec. 15 at 5 p.m. CT.

Illinois Respiratory Disease Surveillance Data

The Infectious Respiratory Disease Surveillance Dashboard from the Illinois Dept. of Public Health (IDPH) provides the latest data on hospital visits, seasonal trends, lab test positivity and demographic data. IDPH also tracks COVID-19, influenza and respiratory syncytial virus information through the Illinois Wastewater Surveillance System dashboard.

Briefly Noted

The U.S. Departments of Health and Human Services, Labor, and Treasury launched the Independent Dispute Resolution (IDR) Gateway, a new platform for group health plans, health insurance issuers, providers, facilities, and providers of air ambulance services and their representatives to manage disputes under the federal IDR process. According to a news release, the IDR Gateway provides a secure, centralized system that streamlines the dispute lifecycle, allowing users to submit, track and manage payment disputes from start to finish.

Leading the News

US Army Delays Detonation of Bomb-Making Chemicals in Iowa as Illinois, Other Officials Raised Concerns
WTTW
The U.S. Army decided to delay Friday's detonation of several tons of bomb-making chemicals in southeast Iowa after an outpouring of public concern that a cloud of lead dust could cause environmental contamination and health problems. The plan is now to carry it out on Monday.


In a joint statement issued Friday, the Department of the Army, Department of Health and Human Services, and Environmental Protection Agency said they are working together to ensure the detonation is conducted as safely as possible.

The hospitals, health systems cutting jobs in 2026
Becker's Hospital Review
A number of hospitals and health systems are reducing their workforces amid ongoing financial strain. Executives have cited a mix of factors, including lower reimbursement, rising labor and supply costs and the need to realign operations, as drivers of these decisions. For many organizations, the moves are part of broader efforts to stabilize finances and preserve long-term sustainability.

IL Senate passes plan expanding healthcare coverage options for retired state employees

WAND TV
The Illinois Senate unanimously passed a bill Wednesday to provide retired state employees more options for healthcare coverage. Lawmakers had to act quickly after a St. Louis hospital announced they will no longer accept Medicare Advantage plans offered by Aetna. Medicare-eligible state retirees currently only have one option for a Medicare Advantage plan. But patients were alerted in October that they may lose access to Barnes-Jewish Hospital over a dispute with Illinois Aetna Medicare Advantage coverage unless they enroll in the Total Retirees Advantage Program.

Illinois Health and Hospital Association published this content on November 20, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 20, 2026 at 22:07 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]